In the last few decades, the incidence of multidrug-resistant and extended spectrum beta-lactamase (MDR/ESBL) Gram-negative (GN) bacteria has progressively increased among lung transplant (LT) recipients. A prompt diagnosis, prevention and management of these pathogens remain the cornerstone for successful organ transplant.
Multi-drug resistant and extended spectrum beta-lactamase Gram-negative bacteria in bilateral lung transplant recipients. Incidence, risk factors and in-hospital mortality
Lunardi, Francesca;
2022-01-01
Abstract
In the last few decades, the incidence of multidrug-resistant and extended spectrum beta-lactamase (MDR/ESBL) Gram-negative (GN) bacteria has progressively increased among lung transplant (LT) recipients. A prompt diagnosis, prevention and management of these pathogens remain the cornerstone for successful organ transplant.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
